88 related articles for article (PubMed ID: 3694533)
1. Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study.
Robertson DA; Genovese A; Levi R
J Pharmacol Exp Ther; 1987 Dec; 243(3):834-9. PubMed ID: 3694533
[TBL] [Abstract][Full Text] [Related]
2. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity.
Robertson DA; Wang DY; Lee CO; Levi R
J Pharmacol Exp Ther; 1988 Apr; 245(1):124-8. PubMed ID: 3361438
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
[TBL] [Abstract][Full Text] [Related]
4. Actions of platelet-activating factor on isolated rat hearts.
Pugsley MK; Salari H; Walker MJ
Circ Shock; 1991 Dec; 35(4):207-14. PubMed ID: 1663843
[TBL] [Abstract][Full Text] [Related]
5. Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action.
Hattori Y; Levi R
J Pharmacol Exp Ther; 1986 Jun; 237(3):719-24. PubMed ID: 3012066
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
Stahl GL; Lefer AM
Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
Shukla SD; Morrison WJ; Dhar A
Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
[TBL] [Abstract][Full Text] [Related]
8. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
Jakubowski A; Olszanecki R; Chlopicki S
J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
11. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro.
Burke JA; Levi R; Guo ZG; Corey EJ
J Pharmacol Exp Ther; 1982 Apr; 221(1):235-41. PubMed ID: 6278136
[TBL] [Abstract][Full Text] [Related]
12. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
13. Inotropic effects of histamine in human myocardium: differentiation between positive and negative components.
Guo ZG; Levi R; Graver LM; Robertson DA; Gay WA
J Cardiovasc Pharmacol; 1984; 6(6):1210-5. PubMed ID: 6084781
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
Alloatti G; Penna C; De Martino A; Montrucchio G; Camussi G
Cardiovasc Res; 1999 Mar; 41(3):611-9. PubMed ID: 10435033
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of vascular actions of PAF.
Piper PJ; Stanton AW; Stewart AG
Int J Tissue React; 1987; 9(1):15-7. PubMed ID: 3036733
[TBL] [Abstract][Full Text] [Related]
16. [Cardiodepressive effect of platelet activating factor].
Vornovitskiĭ EG; Ignat'eva VB; Gollash M; Kulikov VI; Lipatkina LIu
Biull Eksp Biol Med; 1989 Jan; 107(1):27-30. PubMed ID: 2914168
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms.
Shimada T; Hirose T; Matsumoto I; Aikawa T
J Endocrinol; 2005 Feb; 184(2):381-91. PubMed ID: 15684346
[TBL] [Abstract][Full Text] [Related]
19. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.
Handley DA; Lee ML; Saunders RN
Thromb Haemost; 1985 Dec; 54(4):756-9. PubMed ID: 4089809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
